Abstract
Dr. Xiufeng Ye and Dr. Guangfu Chen are both co-corresponding authors.
Accordingly, please make the following two corrections to the paper:
1) Add * to the author Xiufeng Ye.
2) *Address correspondence to Dr. Chen guangfu, szchengf@email.szu.edu.cn or Dr. Xiufeng Ye, szrosexiu@ 126.com, Shenzhen Second People’s Hospital, 3002, Sungang West Road, Shenzhen 518035, China.
Current Neurovascular Research
Title:Erratum: Erythropoietin Gene Polymorphism rs551238 is Associated with a Reduced Susceptibility to Brain Injury in Preterm Infants
Volume: 17 Issue: 3
Author(s): Xiufeng Ye*Guangfu Chen*
Affiliation:
- Shenzhen Second People’s Hospital, 3002, Sungang West Road, Shenzhen 518035,China
- Shenzhen Second People’s Hospital, 3002, Sungang West Road, Shenzhen 518035,China
Abstract: Dr. Xiufeng Ye and Dr. Guangfu Chen are both co-corresponding authors.
Accordingly, please make the following two corrections to the paper:
1) Add * to the author Xiufeng Ye.
2) *Address correspondence to Dr. Chen guangfu, szchengf@email.szu.edu.cn or Dr. Xiufeng Ye, szrosexiu@ 126.com, Shenzhen Second People’s Hospital, 3002, Sungang West Road, Shenzhen 518035, China.
Export Options
About this article
Cite this article as:
Ye Xiufeng *, Chen Guangfu *, Erratum: Erythropoietin Gene Polymorphism rs551238 is Associated with a Reduced Susceptibility to Brain Injury in Preterm Infants, Current Neurovascular Research 2020; 17 (3) . https://dx.doi.org/10.2174/156720261703200929114209
DOI https://dx.doi.org/10.2174/156720261703200929114209 |
Print ISSN 1567-2026 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5739 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Mn (III) Tetrakis (4-Benzoic Acid) Porphyrin Protects Against Neuronal and Glial Oxidative Stress and Death After Spinal Cord Injury
CNS & Neurological Disorders - Drug Targets Biomarkers and Cellular Signal Detection for Alzheimer’s Disease, Stroke, and Immune System Mediated Disorders
Current Neurovascular Research Rationale of Hyperbaric Oxygenation in Cerebral Vascular Insult
Current Vascular Pharmacology Polyphenols and Neuroprotection against Ischemia and Neurodegeneration
Mini-Reviews in Medicinal Chemistry Pseudomonas aeruginosa -Eukaryotic Cell Crosstalk: Mediators, Mechanisms and Implications for the Antimicrobial Therapy
Current Organic Chemistry Decreased Vascular Repair and Neovascularization with Ageing: Mechanisms and Clinical Relevance with an Emphasis on Hypoxia- Inducible Factor-1
Current Molecular Medicine The Neuropathology of Vascular Disease in the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS)
Current Alzheimer Research Weight Loss in Older Persons: New Therapeutic Approaches
Current Pharmaceutical Design The Pulse of Drug Development for Alzheimers Disease
Reviews on Recent Clinical Trials Kinase Inhibitors as Potential Therapeutics for Acute and Chronic Neurodegenerative Conditions
Current Pharmaceutical Design Update on the Role of Neutrophils in Atherosclerotic Plaque Vulnerability
Current Drug Targets Bone Marrow-Derived Mesenchymal Stem Cells Attenuate Amyloid β-Induced Memory Impairment and Apoptosis by Inhibiting Neuronal Cell Death
Current Alzheimer Research Cellular and Molecular Regulation of Inflammatory Pain, Nociception and Hyperalgesia - The Role of the Transcription Factor NF-κB as the Lynchpin Nocisensor: Hyperalgesic or Analgesic Effect?
Current Immunology Reviews (Discontinued) Recent progress in the development of anthrax vaccines
Recent Patents on Biotechnology Connected Speech Deficit as an Early Hallmark of CSF-defined Alzheimer’s Disease and Correlation with Cerebral Hypoperfusion Pattern
Current Alzheimer Research Efficacy and Safety of the Combination of Docetaxel (Taxotere®) with Targeted Therapies in the Treatment of Solid Malignancies
Current Drug Targets The Use of Ghrelin and Ghrelin Receptor Agonists as a Treatment for Animal Models of Disease: Efficacy and Mechanism
Current Pharmaceutical Design Tetrahydrobioterin (BH4) Pathway: From Metabolism to Neuropsychiatry
Current Neuropharmacology Palmitoylethanolamide in Homeostatic and Traumatic Central Nervous System Injuries
CNS & Neurological Disorders - Drug Targets Human Tissue Kallikrein: A New Bullet for the Treatment of Ischemia
Current Pharmaceutical Design